In the Media

1/30/12	Age-Related Macular Degeneration Preclinical Data Published in the European Journal of Neuroscience
11/17/11	UCSF's David Rowitch on Myelin Disorders - NPR
09/23/11	StemCells, Inc. CEO Martin McGlynn Featured on Wall Street Reporter
04/12/11	StemBook - Harvard Stem Cell Institute "First Human Trials of Embryonic Stem Cell-based Therapies Head to the Clinic"
03/01/11	ABC 7 News Video "Bay Area Company to Launch Unique Stem Cell Trial"
02/11/11	"Pace Picks Up for Clinical Trials to Evaluate Stem Cell Therapies"
12/07/10	"StemCells Snags Swissmedic Okay to Start Neural Stem Cell Trial in Spinal Cord Injury"
12/06/10	"StemCells Wins Ok for Spinal Cord Trial"
10/13/10	“Therapeutic Promise of Human Neural Stem Cells”
08/20/10	“Human Neural Stem Cells Restore Motor Function in Mice with Chronic Spinal Cord Injury”
08/19/10	“StemCells, Inc. Shares Jump After News of Promising Paralysis Study”
08/18/10	“Cell Treatment Helps Mice Long After Spine Injury”
06/23/10	MIT Technology Review “Cell Transplants for Macular Degeneration”
03/19/10	“StemCells, Inc. Shifts Approach to Therapies”
10/19/09	“Stem Cell Transplants Stalled Blindness in Rats”

Please Note

Links provided may open web pages or documents that are hosted by third parties and are not maintained by StemCells, Inc. and to which our Privacy Policy does not apply. These links are provided to you for convenience and do not serve as an endorsement by StemCells, Inc. of any information or contacts that you may find on these third party sites.

In the Media

03/01/11

02/11/11

12/07/10

10/13/10

08/20/10

08/19/10

08/18/10

06/23/10

03/19/10

10/19/09

Please Note

Media Contacts

StemCells, Inc.

Email Signup

Please Note!

You are about to open a web page or document that is hosted by a third party and is not maintained by StemCells, Inc. and to which our Privacy Policy does not apply.